The ProScreen Platform

    The commercial platform behind BP+ cardiovascular screening at scale

    ProScreen runs cardiovascular screening across 200+ pharmacy locations in Australia and New Zealand. Multi-tenant SaaS platform, supporting complex or simple operations, and ready to deploy in your market, in your brand, with our infrastructure behind it.

    ProScreen screening results displayed on a laptop next to a Uscom BP+ device
    >20,000
    Screenings delivered
    >200
    Pharmacy locations live
    2 Countries
    Live commercial operations
    Global
    Built for deployment anywhere

    Live commercial operations

    Not a pilot, not a research study. ProScreen has been generating revenue across two countries since 2023, with screenings delivered every day across more than 200 pharmacy locations and expanding.

    ProScreen + Uscom BP+

    The platform and the device, working as one. ProScreen is purpose-built around the BP+ measurement protocol, integrating directly with the device via Web API and capturing the full three-reading clinical sequence on every screening.

    Built on proprietary clinical science

    Proprietary Cardiaction algorithms and business logic, personalised action plans, recall thresholds, and clinical interpretation refined over decades of real-world screening and research. The science is in the platform, not just the device.

    A market that's been waiting for the right platform

    The Uscom BP+ has changed what's possible in cardiovascular screening. It directly measures central blood pressure, arterial stiffness, and other haemodynamic parameters that standard arm-cuff measurement cannot capture. It is a clinically validated, regulatory-cleared device with a substantial body of peer-reviewed research behind it.

    Until now, deploying it commercially at scale has required organisations to build their own operational infrastructure: screener workflows, consumer bookings, clinical reporting, multi-location admin, partner portals, payment processing, payroll integration. That's years of work and millions of dollars before the first paying screening.

    ProScreen is that infrastructure. We've built it, deployed it, and proven it across two countries and more than 200 pharmacy locations. Now we're ready to bring it to other markets, with partners who want to move faster than building from scratch.

    What ProScreen does

    The full operational stack around the BP+, built for screening at scale.

    Screening workflow

    From appointment check-in to BP+ measurement to printed results report. Web API integration with the BP+ device, three-reading protocol with automatic best-reading selection, real-time validation, and full audit trail. Built for screeners with no clinical background to deliver quality screenings safely.

    Consumer experience

    BookNow online appointment booking integrated end-to-end, automated SMS and email reminders, electronic delivery of personalised results, and recall management. Quiet hours enforced. Multi-tenant by design so each market or brand keeps its own consumer-facing identity.

    Clinical reporting

    Personalised PDF reports covering central blood pressure, augmented pressure, arterial stiffness, central pulse pressure, and a personalised action plan. GP letter workflow for elevated findings. PDF access managed with security passwords to read the content.

    Operations

    Screener rostering across multiple locations, pharmacy partner portal for self-service clinic management, recruitment and credentialing workflows, Xero Payroll integration for screener wages in Australia and New Zealand, Stripe for payment processing.

    Multi-tenant by design

    Run multiple brands, countries, or partner organisations on a single platform. Strict data isolation enforced at the database level. Per-tenant configuration of clinical thresholds, branding, pricing, and integrations. White-label ready from day one.

    Research and analytics

    Structured research workbench with access to every screening parameter across every reading. De-identified AI clinical interpretation built into the workflow, with strict separation of personal health information. A clean dataset that grows with every screening.

    Three ways to work with us

    Pick the pathway that fits your business. Each one has a different shape, all of them move quickly.

    License the platform

    For operators ready to deliver screenings in their market

    For pharmacy chains, screening service operators, health systems, and government health agencies who want to deliver cardiovascular screening at scale. We license ProScreen to you, configure it for your operations, train your team, and stand alongside you as you launch.

    What's included:

    • •Full ProScreen platform with all modules
    • •BookNow consumer booking, branded to your market
    • •Onboarding, training, and ongoing technical support
    • •Multi-tenant admin for multi-region operators
    • •Integration support for local payments, scheduling, and payroll

    Best fit: pharmacy chains, dedicated screening service companies, government health programs, large clinic networks.

    Become a reseller

    For partners who already serve our customers

    For organisations already serving healthcare, pharmacy, or screening customers who want to add ProScreen to their offering. Sell ProScreen alongside the BP+ device or your existing services. Recurring revenue per location, with us delivering the platform behind the scenes.

    What's included:

    • •Reseller commercials structured around your customer base
    • •Co-branded sales collateral and demo environment
    • •Direct enablement of your sales team
    • •Technical handover for your customers' deployments

    Best fit: BP+ distributors, healthcare technology resellers, pharmacy software vendors, regional partners with established healthcare relationships.

    Research access

    For researchers working on cardiovascular detection and prevention

    For academic researchers, clinicians, and public health analysts working on cardiovascular detection, prevention, and population health. Structured access to our research-consented dataset via the ProScreen research workbench, under appropriate ethical frameworks. Thousands of records carry express research consent, with every new screening capturing consent going forward.

    What's included:

    • •Access to consented BP+ screening data with full parameter set
    • •Workbench tools for cohort building and analysis
    • •Collaboration on study design where it fits
    • •Co-authorship discussions for publication-track work

    Best fit: universities, research institutes, public health programs, cardiovascular registries.

    Why ProScreen

    The hard part of cardiovascular health screening at scale is not the device. It's everything around the device. ProScreen is what years of running real clinics, in real pharmacies, with real consumers looks like when you turn it into software.

    Built on the Uscom BP+

    TGA ARTG ID 227735, FDA 510(k) K121266. Clinically validated and supported by peer-reviewed research.

    HIPAA-aligned security baseline

    Designed for global deployment, not just AU and NZ.

    Multi-tenant from day one

    Already proven across two countries and 200+ locations on a single platform.

    Direct measurement

    Central systolic pressure, arterial stiffness, augmented pressure, central pulse pressure, ejection duration, heart rate, and brachial BP.

    Active R&D

    New capabilities released monthly. We're not handing you a fixed product.

    Operational depth

    Bookings, recalls, rostering, payroll, partner portals, GP referral workflows. The unsexy work, already done and more!

    Talk to us

    Tell us where you're based and what you're hoping to do. We'll come back to you within two business days.

    We treat all enquiries as confidential.

    Free heart health check · 2 min